Ichimoku entry PAHCChose this one today because another unusual trigger, the lagging span breaking the cloud top. Trying to showcase different entry looks.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.302EUR
29.89 MEUR
896.54 MEUR
20.21 M
About Phibro Animal Health Corporation
Sector
CEO
Jack C. Bendheim
Headquarters
Teaneck
Website
Employees (FY)
1.92 K
Founded
1946
FIGI
BBG006B68HG7
Phibro Animal Health Corp. engages in the development, manufacture, and marketing of animal health and mineral nutrition products. It operates through the following segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops and markets medicated feed additives, nutritional specialty products, and vaccines. The Mineral Nutrition segment includes formulations and concentrations of trace minerals such as zinc, manganese, copper, iron, and compounds. The Performance Products segment produces specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company was founded on May 11, 1946 and is headquartered in Teaneck, NJ.
PAHC: One's Meat Or Poison ?PAHC has been consolidating some of its gains since its near term low formed in Apr 2017.
Prices appears to be forming a 3 wave A-B-C correction which might have already been completed or sub-divide a bit down further before resuming its uptrend.
Average turnover has been decreasing steadily since
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PB8 is 16.200 EUR — it has decreased by 1.82% in the past 24 hours. Watch PHIBRO ANIMAL HEALTH A stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MUN exchange PHIBRO ANIMAL HEALTH A stocks are traded under the ticker PB8.
PB8 stock has fallen by 4.14% compared to the previous week, the month change is a 5.19% rise, over the last year PHIBRO ANIMAL HEALTH A has showed a 32.79% increase.
We've gathered analysts' opinions on PHIBRO ANIMAL HEALTH A future price: according to them, PB8 price has a max estimate of 17.61 EUR and a min estimate of 8.34 EUR. Watch PB8 chart and read a more detailed PHIBRO ANIMAL HEALTH A stock forecast: see what analysts think of PHIBRO ANIMAL HEALTH A and suggest that you do with its stocks.
PB8 stock is 1.85% volatile and has beta coefficient of 0.80. Track PHIBRO ANIMAL HEALTH A stock price on the chart and check out the list of the most volatile stocks — is PHIBRO ANIMAL HEALTH A there?
Today PHIBRO ANIMAL HEALTH A has the market capitalization of 659.14 M, it has decreased by 1.59% over the last week.
Yes, you can track PHIBRO ANIMAL HEALTH A financials in yearly and quarterly reports right on TradingView.
PHIBRO ANIMAL HEALTH A is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
PB8 earnings for the last quarter are 0.29 EUR per share, whereas the estimation was 0.27 EUR resulting in a 6.90% surprise. The estimated earnings for the next quarter are 0.31 EUR per share. See more details about PHIBRO ANIMAL HEALTH A earnings.
PHIBRO ANIMAL HEALTH A revenue for the last quarter amounts to 243.93 M EUR despite the estimated figure of 235.07 M EUR. In the next quarter revenue is expected to reach 240.44 M EUR.
PB8 net income for the last quarter is 7.79 M EUR, while the quarter before that showed 1.15 M EUR of net income which accounts for 574.86% change. Track more PHIBRO ANIMAL HEALTH A financial stats to get the full picture.
Yes, PB8 dividends are paid quarterly. The last dividend per share was 0.11 EUR. As of today, Dividend Yield (TTM)% is 2.72%. Tracking PHIBRO ANIMAL HEALTH A dividends might help you take more informed decisions.
PHIBRO ANIMAL HEALTH A dividend yield was 3.50% in 2023, and payout ratio reached 59.63%. The year before the numbers were 2.51% and 39.54% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jun 1, 2024, the company has 1.92 K employees. See our rating of the largest employees — is PHIBRO ANIMAL HEALTH A on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PHIBRO ANIMAL HEALTH A EBITDA is 87.39 M EUR, and current EBITDA margin is 11.66%. See more stats in PHIBRO ANIMAL HEALTH A financial statements.
Like other stocks, PB8 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHIBRO ANIMAL HEALTH A stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHIBRO ANIMAL HEALTH A technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHIBRO ANIMAL HEALTH A stock shows the buy signal. See more of PHIBRO ANIMAL HEALTH A technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.